All In Biotech

Drug Trial Radar · NCT03894215

RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer

A Two-arm, Randomized, Non-comparative, Phase 2 Trial of AGEN2034 (Anti-PD-1) as a Monotherapy or Combination Therapy With AGEN1884 (Anti- CTLA4) or With Placebo in Women With Recurrent Cervical Cancer (Second Line) - RaPiDS

Last checked: Nov 19, 2026Latest source record: Mar 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingRandomized with 211 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

211

Actual

Start

Jun 1, 2019

Primary completion

Mar 26, 2025

Study completion Mar 26, 2025

Sponsor

Lead sponsor
Agenus Inc.Industry
Sponsor type
Industry
Collaborators
GOG Foundation
First posted
Mar 28, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a randomized, blinded, non-comparative, two-arm Phase 2 clinical trial to assess the efficacy and safety of AGEN2034 administered with placebo (Treatment Arm 1 - monotherapy) or with AGEN1884 (Treatment Arm 2- combination therapy) for treatment of patients with advanced cervical cancer who relapsed or progressed after receiving first-line platinum-based chemotherapy. The study is not intended to compare the efficacy of the 2 experimental arms. Rather, the efficacy of each arm will be evaluated against its relevant historical controls as appropriate.

Conditions

  • Cervical Cancer

Interventions

  • AGEN2034Drug

    PD-1 antibody

  • AGEN1884Drug

    CTLA-4 antibody

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Objective Response RateTime frame: 48 months

Locations

68 sites in 7 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham School of Medicine

    Birmingham, Alabama

  • University of South Alabama Mitchell Cancer Institute

    Mobile, Alabama

  • Arizona Oncology - Biltmore Cancer Center

    Phoenix, Arizona

  • Arizona Oncology - Tucson - Wilmot Road Location

    Tucson, Arizona

  • University of California, San Diego (UCSD) - Moores Cancer Center

    La Jolla, California

  • UCLA- Women's Health Clinical Research Unit (WHCRU)

    Los Angeles, California

  • Gynecologic Oncology Associates

    Newport, California

  • California Pacific Medical Center

    San Francisco, California

  • University of California, San Francisco Medical Center

    San Francisco, California

  • Baptist MD Anderson Cancer Center

    Jacksonville, Florida

  • Moffitt Cancer Center

    Tampa, Florida

  • Northside Hospital

    Atlanta, Georgia

  • St Joseph's Hospital

    Savannah, Georgia

  • Community Health Network - North Cancer Center

    Indianapolis, Indiana

  • University of Kentucky Albert B. Chandler Hospital

    Lexington, Kentucky

  • Ochsner Clinic Foundation

    New Orleans, Louisiana

  • MD Anderson Cancer Center at Cooper

    Camden, New Jersey

  • University of New Mexico Cancer Center

    Albuquerque, New Mexico

  • Northwell Health Monter Cancer Center

    Lake Success, New York

  • Laura and Isaac Perlmutter Cancer Center at NYU Langone

    New York, New York

  • SUNY Upstate Medical University

    Syracuse, New York

  • Albert Einstein College of Medicine

    The Bronx, New York

  • Levine Cancer Institute

    Charlotte, North Carolina

  • FirstHealth Outpatient Cancer Center

    Pinehurst, North Carolina

  • MetroHealth Medical Center

    Cleveland, Ohio

  • The Ohio State University Wexner Medical Center

    Columbus, Ohio

  • Columbus NCORP

    Columbus, Ohio

  • Stephenson Cancer Center

    Oklahoma City, Oklahoma

  • Oklahoma Cancer Specialists and Research Institute, LLC

    Tulsa, Oklahoma

  • Willamette Valley Cancer Institute

    Eugene, Oregon

  • Northwest Cancer Specialists, P.C.

    Portland, Oregon

  • Penn Medicine - Jordan Center for Gynecologic Cancer

    Philadelphia, Pennsylvania

  • WellSpan Gynecologic Oncology

    York, Pennsylvania

  • Women & Infants Hospital of Rhode Island

    Providence, Rhode Island

  • Texas Oncology Surgical Specialists - Austin Central

    Austin, Texas

  • Texas Oncology - Bedford

    Bedford, Texas

  • Texas Oncology - Dallas - Presbyterian Cancer Center

    Dallas, Texas

  • The University of Texas Southwestern Medical Center

    Dallas, Texas

  • Texas Oncology - Fort Worth Cancer Center

    Fort Worth, Texas

  • Texas Oncology - San Antonio Medical Center

    San Antonio, Texas

Showing 40 of 68 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.